BRPI0412904A - processo para a preparação de inibidores de cpla2 - Google Patents

processo para a preparação de inibidores de cpla2

Info

Publication number
BRPI0412904A
BRPI0412904A BRPI0412904-0A BRPI0412904A BRPI0412904A BR PI0412904 A BRPI0412904 A BR PI0412904A BR PI0412904 A BRPI0412904 A BR PI0412904A BR PI0412904 A BRPI0412904 A BR PI0412904A
Authority
BR
Brazil
Prior art keywords
compound
formula
preparation
inhibitors
preparing
Prior art date
Application number
BRPI0412904-0A
Other languages
English (en)
Inventor
Yanzhong Wu
Panolil Raveendranath
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0412904A publication Critical patent/BRPI0412904A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/38—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reaction of ammonia or amines with sulfonic acids, or with esters, anhydrides, or halides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE INIBIDORES DE CPLA~ 2~". A presente invenção refere-se a um processo para preparação de um composto de fórmula (I) na qual o composto HC=-C-(CH~ 2~)~ n~ -NH~ 2~ é reagido com o composto R~ 1~-SO~ 2~CI para produzir um composto intermediário, composto intermediário o qual é então reagido com o composto de fórmula (II) para produzir o composto de fórmula (1). Os termos R~ 1~, R~ 2~, R~ 3~, R~ 4~ e n têm as definições indicadas nas reivindicações. Os compostos de fórmula (I) são úteis na preparação de derivados indóis de fórmula (V) que são inibidores cPLA~ 2~.
BRPI0412904-0A 2003-07-25 2004-07-19 processo para a preparação de inibidores de cpla2 BRPI0412904A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49000503P 2003-07-25 2003-07-25
PCT/US2004/023247 WO2005012238A1 (en) 2003-07-25 2004-07-19 Process for the preparation of cpla2 inhibitors

Publications (1)

Publication Number Publication Date
BRPI0412904A true BRPI0412904A (pt) 2006-09-26

Family

ID=34115341

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412904-0A BRPI0412904A (pt) 2003-07-25 2004-07-19 processo para a preparação de inibidores de cpla2

Country Status (14)

Country Link
US (2) US6891065B2 (pt)
EP (1) EP1648861B1 (pt)
JP (1) JP4607877B2 (pt)
CN (1) CN100577640C (pt)
AR (1) AR045089A1 (pt)
AT (1) ATE432918T1 (pt)
AU (1) AU2004261567A1 (pt)
BR (1) BRPI0412904A (pt)
CA (1) CA2528174C (pt)
DE (1) DE602004021388D1 (pt)
ES (1) ES2325265T3 (pt)
MX (1) MXPA06000406A (pt)
TW (1) TW200510305A (pt)
WO (1) WO2005012238A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
TW200510305A (en) 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7342119B2 (en) * 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
AR053410A1 (es) 2004-08-19 2007-05-09 Wyeth Corp Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
KR100746342B1 (ko) 2006-04-10 2007-08-03 한국과학기술원 구리 촉매 존재하에서 ｎ―설포닐아미드 화합물의 제조방법
CN100363341C (zh) * 2006-05-12 2008-01-23 北京化工大学 旋光性n-炔丙磺酰胺聚合物及其制备方法
US20100093725A1 (en) * 2006-10-31 2010-04-15 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
US20100113443A1 (en) * 2006-10-31 2010-05-06 Wyeth Liquid formulations of phospholipase enzyme inhibitors
US8113207B2 (en) * 2008-08-22 2012-02-14 Kimberly-Clark Worldwide, Inc. Self-conforming sound attenuation earplug
CN102617558A (zh) * 2012-03-26 2012-08-01 上海泛凯生物医药科技有限公司 一种维拉佐酮的制备方法
CN110437125B (zh) * 2019-09-06 2021-03-12 苏州旺山旺水生物医药有限公司 一种Tezacaftor中间体II的制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5461075A (en) * 1988-06-17 1995-10-24 The Procter & Gamble Company Use of vanilloids for the prevention of lesions due to herpes simplex infections
US5186736A (en) * 1988-08-02 1993-02-16 Hoechst Aktiengesellschaft Heterocyclic N-acylsulfonamides and their use as herbicides or growth regulators
DE3826230A1 (de) * 1988-08-02 1990-02-08 Hoechst Ag Heterocyclische n-acylsufonamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren
JPH02115157A (ja) * 1988-10-24 1990-04-27 Hokko Chem Ind Co Ltd スルホニルグリシン誘導体および除草剤
CA2017383A1 (en) 1989-06-08 1990-12-08 Raymond R. Martodam Use of vanilloids for the treatment of respiratory diseases or disorders
DE3935277A1 (de) 1989-10-24 1991-05-02 Hoechst Ag Sulfonierte heterocyclische carboxamide, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung als herbizide oder wachstumsregulatoren
GB9201755D0 (en) 1992-01-28 1992-03-11 British Bio Technology Compounds
AU1110095A (en) * 1993-12-20 1995-07-10 Bayer Aktiengesellschaft N-cyanoaryl nitrogen heterocycles with sulphur-containing groupings
DE4431218A1 (de) * 1994-09-02 1996-03-07 Bayer Ag Substituierte Pyrimidin(thi)one
DE19528305A1 (de) 1995-08-02 1997-02-06 Bayer Ag Substituierte Phenyluracile
DE19601626A1 (de) 1996-01-18 1997-07-24 Bayer Ag Substituierte N-Aryl-Stickstoffheterocyclen
DE19606594A1 (de) 1996-02-22 1997-08-28 Bayer Ag Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one
EP0922028A1 (en) * 1996-08-26 1999-06-16 Genetics Institute, Inc. Inhibitors of phospholipase enzymes
SK12742000A3 (sk) * 1998-02-25 2001-05-10 Genetics Institute, Inc. Inhibítory fosfolipázových enzýmov, farmaceutický prostriedok s ich obsahom a ich použitie
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
AU2001267879A1 (en) * 2000-07-05 2002-01-14 Ajinomoto Co., Inc. Acylsulfonamide derivatives
DE10043790A1 (de) 2000-09-06 2002-03-14 Bayer Ag Substituierte 1-Aryl-pyridin-2-(thi)one
JP2004523490A (ja) 2000-11-28 2004-08-05 ギルフォード ファーマシュウティカルズ インコーポレイテッド 二置換カルボサイクリックサイクロフィリン結合化合物とその用途
MXPA03006666A (es) * 2001-01-25 2004-05-31 Guilford Pharm Inc Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
WO2003022051A1 (en) 2001-09-06 2003-03-20 Syngenta Participations Ag Herbicidal n-alkylsulfonamino derivatives
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
TWI334778B (en) * 2001-12-03 2010-12-21 Wyeth Corp Inhibitors of cytosolic phospholipase a2
US6797708B2 (en) * 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
TW200510305A (en) 2003-07-25 2005-03-16 Wyeth Corp Process for the preparation of CPLA2 inhibitors
US7582771B2 (en) 2003-09-03 2009-09-01 Wyeth Process for the synthesis of cPLA2 inhibitors
US7342119B2 (en) 2003-09-30 2008-03-11 Wyeth Holdings Corporation Process for the synthesis of a CPLA2 inhibitor
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles

Also Published As

Publication number Publication date
CA2528174C (en) 2012-03-13
MXPA06000406A (es) 2006-03-17
CN1816522A (zh) 2006-08-09
AU2004261567A1 (en) 2005-02-10
TW200510305A (en) 2005-03-16
JP2007500190A (ja) 2007-01-11
WO2005012238A1 (en) 2005-02-10
JP4607877B2 (ja) 2011-01-05
US20050159613A1 (en) 2005-07-21
DE602004021388D1 (de) 2009-07-16
US6891065B2 (en) 2005-05-10
CA2528174A1 (en) 2005-02-10
EP1648861B1 (en) 2009-06-03
CN100577640C (zh) 2010-01-06
AR045089A1 (es) 2005-10-12
US20050020858A1 (en) 2005-01-27
ES2325265T3 (es) 2009-08-31
EP1648861A1 (en) 2006-04-26
ATE432918T1 (de) 2009-06-15
US7259277B2 (en) 2007-08-21

Similar Documents

Publication Publication Date Title
BR0215493A (pt) Processo para preparação de ésteres escopìnicos
BR0115580A (pt) Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2
EA201070186A1 (ru) Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа
BR0212185A (pt) Compostos e métodos para a preparação de compostos
NO20082243L (no) Fremgangsmater og forbindelser for fremstiliing av CC-1065 analoger
BRPI0411268A (pt) processo para a preparação de um composto 3-aril butil-amina substituìdo
BRPI0510410A (pt) compostos orgánicos
BRPI0413973A (pt) compostos
BRPI0500480A (pt) processo para a sìntese de (1s)-4,5-dimetóxi- 1-(metilaminometil)-benzociclobutano e sais de adição deste, e aplicação na sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
BR0208992A (pt) Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
EA200970497A1 (ru) Производные пиррола, их получение и их применение в терапии
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
GT200600251A (es) Intermediarios utiles en la sintesis de moduladores de alquilquinolina y alquilquinazolina quinasa y metodos de sintesis relacionados.
BR0316702A (pt) xprocesso para preparação de (s)-pantoprazol
CY1112279T1 (el) Εποξειδικη ενωση και μεθοδος για την παρασκευη της
BR0309130A (pt) Derivados de acil-3-carboxifenil-uréia, processo para a sua preparação e sua aplicação
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
CY1107481T1 (el) Εναντιοεκλεκτικη αλκυλιωση τρικυκλικων ενωσεων

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 8A ANUIDADE.